BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37421997)

  • 1. Annular skin tumors and lymphoproliferative diseases.
    Baykal C; Ekinci AP
    Clin Dermatol; 2023; 41(3):382-395. PubMed ID: 37421997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annular skin tumors and lymphoproliferative diseases.
    Baykal C; Polat Ekinci A
    Clin Dermatol; 2023; 41(6):692-711. PubMed ID: 37586571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion.
    Gonthier DM; Hartman G; Holley JL
    Am J Kidney Dis; 1992 Jun; 19(6):600-3. PubMed ID: 1595711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Kerl H
    Semin Cutan Med Surg; 1999 Mar; 18(1):64-70. PubMed ID: 10188844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic validation of capillary electrophoresis analysis of T-cell receptor gamma-chain gene rearrangements: prediction of malignant transformation of cutaneous T-cell lymphoproliferative disorders.
    Chang TL; Salto-Tellez M; Thamboo TP; Lee YS; Koay ES
    Clin Chem; 2003 Mar; 49(3):513-5. PubMed ID: 12600972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dermatology for general physicians].
    Itin P
    Praxis (Bern 1994); 2013 Jan; 102(2):85-9. PubMed ID: 23384951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiocentric cutaneous lymphoproliferative disorders].
    Bachelez H
    Ann Dermatol Venereol; 2000 Jan; 127(1):97-100. PubMed ID: 10717574
    [No Abstract]   [Full Text] [Related]  

  • 9. T-cell receptor gene rearrangement studies as a diagnostic tool in lymphoproliferative skin diseases.
    Lessin SR; Rook AH
    Exp Dermatol; 1993 Mar; 2(2):53-62. PubMed ID: 8156170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphadenosis benigna cutis versus primary cutaneous B-cell lymphomas of follicular center cell origin.
    Rijlaarsdam JU; Meijer CJ; Willemze R
    Curr Probl Dermatol; 1990; 19():189-95. PubMed ID: 2404676
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
    Evans HL; Winkelmann RK; Banks PM
    Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extra-lymphnodal pseudolymphoma].
    Eusebi V; Giangaspero F; Bondi A
    Recenti Prog Med; 1979 Aug; 67(2):267-87. PubMed ID: 388554
    [No Abstract]   [Full Text] [Related]  

  • 13. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiples in dermatology: markers for special considerations in diagnosis, therapy, and prognosis.
    Trevino J; Grosshandler J; Chen AY; Chiang C; Serrao R; Dohil M
    J Drugs Dermatol; 2012 Jul; 11(7):812-7. PubMed ID: 22777221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders.
    Cerroni L; Kerl H
    Dermatol Clin; 1994 Apr; 12(2):219-29. PubMed ID: 8045034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous semiology of hematoderma].
    Crickx B; Belaich S
    Rev Prat; 1981 Nov; 31(51):3701-2 passim. PubMed ID: 7302498
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
    Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermoscopy of Cutaneous Lymphoproliferative Disorders: Where Are We Now?
    Piccolo V; Russo T; Agozzino M; Vitiello P; Caccavale S; Alfano R; Argenziano G
    Dermatology; 2018; 234(3-4):131-136. PubMed ID: 30032152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous involvement of polymorphic post-transplant lymphoproliferative disorder in a child after liver transplantation.
    Chen KY; Lin CY; Kuo TT; Shih LY; Chang CH; Chen WT; Yang CY
    Pediatr Dermatol; 2019 Sep; 36(5):681-685. PubMed ID: 31215060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
    Bakr F; Wain EM; Barlow R; Robson A
    Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.